AIRS is down -11.37% at $3.04 during Monday’s regular session (3:16 PM ET), versus Friday’s close of $3.43. The selling extends post-Q2-earnings volatility: revenue fell to $42.9M from $44.01M, net loss widened, and FY26 revenue guidance was reaffirmed only at the lower end of $151M-$157M.
NIVF shares fell roughly 59.9% over the 30 days through the August 13, 2026 close, declining from $1.37 to about $0.55. The move extends a deeper downtrend, with the stock down approximately 79.6% over the trailing three months.
Starling Oncology, Inc. recently raised its full-year 2026 revenue guidance to a range of $650 million to $670 million, signaling confidence in operational scaling and contract expansion. Analyst consensus stands at a "Strong Buy" rating with an average price target of approximately $9.00, reflecting optimism around the company's positioning in value-based cancer care.
DVA tumbled -14.91% intraday on August 5, extending a -6.5% after-hours decline on August 4 after the company reported Q2 2026 results. Q2 adjusted EPS of $4.02 and revenue of $3.55B both beat consensus estimates, but the top-and-bottom-line beat was overshadowed by cautious forward commentary.
$300 price target: A roughly 18% advance from the late-July closing price of $254.78, representing a psychological milestone that sits between the average analyst target of $277 and the Street-high forecast of $309. Strongest bullish factors: Aggressive share buybacks that have retired over 10% of outstanding shares, a dominant ambulatory surgery platform through USPI, and consistent earnings beats across multiple quarters.
PACS Group shares have risen approximately 6% over the last 30 days, pushing the stock near its 52-week high and extending a broader multi-month uptrend. The company operates 324 post-acute care facilities across 17 states, positioning it as one of the largest skilled nursing providers in the United States.
ACHC closed at $34.51 on Friday, gaining +1.47% (+$0.50) during the regular session from Thursday's close of $34.01, continuing a powerful multi-week rally ahead of its Q2 earnings report. The primary catalyst is pre-earnings positioning: Q2 2026 results are due Tuesday, July 28 after market close, with consensus estimates at $0.33 EPS on $848.1M revenue and management guidance of $0.30–$0.40 EPS.
PACS Group shares surged approximately 24% over the past 30 days, climbing from $36.25 on June 15 to $44.95 on July 14, 2026. The primary catalyst was the announcement of a definitive agreement to acquire operations of 34 skilled nursing facilities across six western states from Eduro Healthcare.
LifeStance Health Group (LFST) surged approximately 28% over the last 30 days, climbing from $8.50 on June 12 to $10.88 by July 13, 2026. Strong Q1 2026 earnings reported in early May continued to reverberate, with revenue up 21% year-over-year to $403.5 million and EPS of $0.04 beating consensus estimates by 300%.
HCA stock declined -10% over the past 30 days, primarily due to a sharp post-earnings selloff following Q1 results that revealed weaker patient volumes from a mild respiratory season and weather disruptions. Over the past quarter, shares fell -13%, erasing earlier gains from strong prior-quarter earnings amid rising costs, moderating admission growth, and sector pressures.
Shares of ACHC are declining approximately 15.00% on Thursday, April 30, 2026, falling from a prior close of approximately $28.27 to approximately $24.03, as Q1 2026 results released after Wednesday's close delivered a headline beat that was entirely overshadowed by weak Q2 2026 guidance and a catastrophic operating margin collapse from 5.5% to just 1.3% year-over-year.
OPCH shares are plunging approximately 27% in premarket trading on April 30, 2026, from a prior session close of $26.87 to roughly $19.62. The primary catalyst is a significant revenue miss in Q1 2026, with net revenue of $1.35 billion coming in well below the Wall Street consensus estimate of approximately $1.40 billion.
Shares of AGL are declining approximately 14% in Tuesday's session on April 21, 2026, falling from a prior close of $28.30 to approximately $24.34, as mounting structural headwinds in the Medicare Advantage value-based care sector and broader healthcare market turbulence weigh heavily on investor sentiment.
AirSculpt Technologies, Inc. (
AIRS) stands out as a leading provider of minimally invasive body contouring procedures through its Elite Body Sculpture brand. The company specializes in proprietary AirSculpt treatments that remove fat and tighten skin without general anesthesia. These include options like AirSculpt+, AirSculpt Smooth for cellulite reduction, and specialized fat transfer procedures such as Power BBL for Brazilian butt lifts, Up a Cup for breast enhancement, and Hip Flip for hourglass contouring. Based in Miami Beach, Florida, and founded in 2012,
AIRS operates centers across the United States, Canada, and the United Kingdom.
Shares of UHS fell approximately 9.15% on February 26, 2026, closing near $209.62, down from a prior close of $230.73. The primary catalyst was a mixed Q4 2025 earnings report: adjusted EPS of $5.88 missed the consensus estimate of $5.92, and revenue of $4.49 billion fell short of the $4.50–$4.51 billion analyst forecast.
The Other Transportation industry has witnessed a remarkable surge of +11.1% in its performance over the past week, catching the attention of investors and analysts alike. This article delves into the exciting developments within this industry, with a specific focus on two key tickers: ASLE and UP.
Explore the potential of Therapy theme stocks showing a stellar 1-week gain of 10.96%. Understand our Long-Short Equity Strategy delivering a 64% annualized return, and High Capitalization Swing trading with a 7% annual return. Discover key insights on $ACRS, $ALLO, $ALNY, and others.
"Join us as we uncover the reasons behind WW International's (WW) significant -12.99% descent this month. We'll explore the landscape of the Other Consumer Services Industry, analyze prevailing trends, and shed light on the factors influencing WW International's performance."
Discover how AirSculpt Technologies (AIRS) skyrocketed +31.51% in just one month! Find out why A.I. analysis predicts a continued upward trend and potential correlations with SGRY in our latest blog post.
WW International (WW) is a multinational wellness organization that offers clients assistance in maintaining a healthy weight and way of life. The business uses a variety of platforms, including internet, workshops, and private coaching. Recently, the price of WW's stock has been on a roller coaster, rising by almost 80% in the last three days. There are nonetheless hints that the stock may...